AK
Alok Kumar Singh
About Alok Kumar Singh
Data last updated:
Alok Kumar Singh is a Director at Genovet Pharma Private Limited (since 2024) and Designated Partner at Nutro Vet Pharma Llp (since 2024). The largest current company by reported revenue is Genovet Pharma Private Limited at ₹54.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genovet Pharma Private Limited U75000WB2024PTC271053 | Director | 31 May 2024 | 2024 | ₹54.6 Lakh (FY 2025) | Active |
| Nutro Vet Pharma Llp ACH-3645 | Designated Partner | 26 May 2024 | 2024 | Active |
Board colleagues of Alok Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rohit Kumar | 10651805 | Genovet Pharma Private Limited | Director |
| Irshad Hussain | 10643721 | Nutro Vet Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Alok Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alok Kumar Singh
Alok Kumar Singh currently holds 2 directorships: Genovet Pharma Private Limited (Director, since 31 May 2024, revenue ₹54.6 Lakh (FY 2025)); Nutro Vet Pharma Llp (Designated Partner, since 26 May 2024).
Alok Kumar Singh was first appointed on 26 May 2024 as Designated Partner at Nutro Vet Pharma Llp.
The current boards of Alok Kumar Singh's companies include Rohit Kumar (Genovet Pharma Private Limited), Irshad Hussain (Nutro Vet Pharma Llp).